Infant Bacterial Therapeutics is appointing Anders Kronström as Chief Technical Officer. Anders brings to the company significant experience from the pharmaceutical industry and will strengthen the team with a broad knowledge and expertise in pharmaceutical drug development.
 
See Who we are here